Tenax Therapeutics, Inc. (TENX) stock
TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.42−0.06 (-4.05%)
Close on Nov 17, 2026Market cap $53.14MP/E –Yield –
Tenax Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Tenax Therapeutics's pe ratio was 155.5× on Jan 31, 2024.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Jan 31, 2024 | 155.5× | −105.6 |
| 2023 | Dec 29, 2023 | 261.1× | – |
See a number that looks wrong?